cupferron
superoxide dismutase inhibitor; RN given refers to parent cpd; structure
Also Known As:
N-nitroso-N-phenylhydroxylamine; N-nitroso-N-phenylhydroxylamine ammonium salt; hydrogen cupferron; azane; N-hydroxy-N-phenylnitrous amide
Networked: 7
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Chromosome Aberrations (Chromosome Abnormalities)
06/01/1959
- " Studies on the production of chromosomal aberrations by visible light: the effects of cupferron, nitric oxide and wavelength." 05/25/1959
- " Cyanide, azide, and cupferron, which strongly inhibited respiration, also increased the frequencies of chromosome aberrations produced by x-rays at low oxygen pressures. " 05/25/1959
- " Nitrosophenylhydroxylamine-ammonium (cupferron), potassium cyanide, sodium azide, ethylenediaminetetraacetate (EDTA), alpha,alpha'-dipyridyl, and o-phenanthroline were tested (1) for their ability to enhance the frequencies of chromosomal aberrations produced by x-rays in the root tip cells of the broad bean, Vicia faba, and (2) for their ability to inhibit oxygen consumption of excised roots of the same plant. "
|
2. | Prostatic Neoplasms (Prostate Cancer)
|
3. | Neoplasms (Cancer)
|
4. | Hepatocellular Carcinoma (Hepatoma)
|
5. | Hemolysis
|
|
Related Drugs and Biologics
Related Therapies and Procedures